Public Health Program for Decreasing Risk for Ebola Virus Disease Resurgence from Survivors of the 2013-2016 Outbreak, Guinea

Overview

Journal Emerg Infect Dis

Specialty Infectious Diseases

Date 2020 Jan 22

PMID 31961292

Citations 4

Authors

Mory Keita

Sakoba Keita

Boubacar Diallo

Momo Camara

Samuel Mesfin

Koumpingnin Yacouba Nebie

NFaly Magassouba

Seydou Coulibaly

Boubacar Barry

Mamadou Oury Balde

Raymond Pallawo

Sadou Sow

Amadou Bailo Diallo

Pierre Formenty

Mamoudou Harouna Djingarey

Ibrahima Soce Fall

Lorenzo Subissi

Affiliations

Soon will be listed here.

Abstract

At the end of the 2013-2016 Ebola virus disease outbreak in Guinea, we implemented an alert system for early detection of Ebola resurgence among survivors. Survivors were asked to report health alerts in their household and provide body fluid specimens for laboratory testing. During April-September 2016, a total of 1,075 (88%) of 1,215 survivors participated in the system; follow up occurred at a median of 16 months after discharge (interquartile range 14-18 months). Of these, 784 acted as focal points and reported 1,136 alerts (including 4 deaths among survivors). A total of 372 (91%) of 408 eligible survivors had >1 semen specimen tested; of 817 semen specimens, 5 samples from 4 survivors were positive up to 512 days after discharge. No lochia (0/7) or breast milk (0/69) specimens tested positive. Our findings underscore the importance of long-term monitoring of survivors' semen samples in an Ebola-affected country.

Citing Articles

rVSV-ZEBOV vaccination in people with pre-existing immunity to Ebolavirus: an open-label safety and immunogenicity study in Guinean communities affected by Ebola virus disease (l'essai proches).

Watson C, Gsell P, Hall Y, Camacho A, Riveros X, Enwere G BMC Med. 2024; 22(1):523.

PMID: 39511527 PMC: 11545826. DOI: 10.1186/s12916-024-03726-z.

How has Guinea learnt from the response to outbreaks? A learning health system analysis.

Millimouno T, Meessen B, Van De Put W, Garcia M, Camara B, Christou A BMJ Glob Health. 2023; 8(2).

PMID: 36854489 PMC: 9980363. DOI: 10.1136/bmjgh-2022-010996.

Investigation of and Strategies to Control the Final Cluster of the 2018-2020 Ebola Virus Disease Outbreak in the Eastern Democratic Republic of Congo.

Keita M, Polonsky J, Finci I, Mbala-Kingebeni P, Ilumbulumbu M, Dakissaga A Open Forum Infect Dis. 2022; 9(9):ofac329.

PMID: 36168547 PMC: 9499850. DOI: 10.1093/ofid/ofac329.

Presence of Ebola virus in breast milk and risk of mother-to-child transmission: synthesis of evidence.

Medina-Rivera M, Centeno-Tablante E, Finkelstein J, Rayco-Solon P, Pena-Rosas J, Garcia-Casal M Ann N Y Acad Sci. 2020; 1488(1):33-43.

PMID: 33113592 PMC: 8048832. DOI: 10.1111/nyas.14519.

References

Mate S, Kugelman J, Nyenswah T, Ladner J, Wiley M, Cordier-Lassalle T . Molecular Evidence of Sexual Transmission of Ebola Virus. N Engl J Med. 2015; 373(25):2448-54. PMC: 4711355. DOI: 10.1056/NEJMoa1509773. View

Subissi L, Keita M, Mesfin S, Rezza G, Diallo B, Van Gucht S . Ebola Virus Transmission Caused by Persistently Infected Survivors of the 2014-2016 Outbreak in West Africa. J Infect Dis. 2018; 218(suppl_5):S287-S291. PMC: 6249578. DOI: 10.1093/infdis/jiy280. View

Sissoko D, Duraffour S, Kerber R, Kolie J, Beavogui A, Camara A . Persistence and clearance of Ebola virus RNA from seminal fluid of Ebola virus disease survivors: a longitudinal analysis and modelling study. Lancet Glob Health. 2016; 5(1):e80-e88. DOI: 10.1016/S2214-109X(16)30243-1. View

Rieger T, Kerber R, Halas H, Pallasch E, Duraffour S, Gunther S . Evaluation of RealStar Reverse Transcription-Polymerase Chain Reaction Kits for Filovirus Detection in the Laboratory and Field. J Infect Dis. 2016; 214(suppl 3):S243-S249. PMC: 5050472. DOI: 10.1093/infdis/jiw246. View

Subtil F, Delaunay C, Keita A, Sow M, Toure A, Leroy S . Dynamics of Ebola RNA Persistence in Semen: A Report From the Postebogui Cohort in Guinea. Clin Infect Dis. 2017; 64(12):1788-1790. DOI: 10.1093/cid/cix210. View

Coltart C, Lindsey B, Ghinai I, Johnson A, Heymann D . The Ebola outbreak, 2013-2016: old lessons for new epidemics. Philos Trans R Soc Lond B Biol Sci. 2017; 372(1721). PMC: 5394636. DOI: 10.1098/rstb.2016.0297. View

Deen G, Broutet N, Xu W, Knust B, Sesay F, McDonald S . Ebola RNA Persistence in Semen of Ebola Virus Disease Survivors - Final Report. N Engl J Med. 2015; 377(15):1428-1437. PMC: 5798881. DOI: 10.1056/NEJMoa1511410. View

Varkey J, Shantha J, Crozier I, Kraft C, Lyon G, Mehta A . Persistence of Ebola Virus in Ocular Fluid during Convalescence. N Engl J Med. 2015; 372(25):2423-7. PMC: 4547451. DOI: 10.1056/NEJMoa1500306. View

Etard J, Sow M, Leroy S, Toure A, Taverne B, Keita A . Multidisciplinary assessment of post-Ebola sequelae in Guinea (Postebogui): an observational cohort study. Lancet Infect Dis. 2017; 17(5):545-552. DOI: 10.1016/S1473-3099(16)30516-3. View

10.

Rodriguez L, de Roo A, Guimard Y, Trappier S, Sanchez A, Bressler D . Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995. J Infect Dis. 1999; 179 Suppl 1:S170-6. DOI: 10.1086/514291. View

11.

Keita M, Duraffour S, Loman N, Rambaut A, Diallo B, Magassouba N . Unusual Ebola Virus Chain of Transmission, Conakry, Guinea, 2014-2015. Emerg Infect Dis. 2016; 22(12):2149-2152. PMC: 5189159. DOI: 10.3201/eid2212.160847. View

12.

Jacobs M, Rodger A, Bell D, Bhagani S, Cropley I, Filipe A . Late Ebola virus relapse causing meningoencephalitis: a case report. Lancet. 2016; 388(10043):498-503. PMC: 4967715. DOI: 10.1016/S0140-6736(16)30386-5. View

13.

Soka M, Choi M, Baller A, White S, Rogers E, Purpura L . Prevention of sexual transmission of Ebola in Liberia through a national semen testing and counselling programme for survivors: an analysis of Ebola virus RNA results and behavioural data. Lancet Glob Health. 2016; 4(10):e736-43. DOI: 10.1016/S2214-109X(16)30175-9. View

14.

Purpura L, Soka M, Baller A, White S, Rogers E, Choi M . Implementation of a National Semen Testing and Counseling Program for Male Ebola Survivors - Liberia, 2015-2016. MMWR Morb Mortal Wkly Rep. 2016; 65(36):963-6. DOI: 10.15585/mmwr.mm6536a5. View

15.

Abad N, Malik T, Ariyarajah A, Ongpin P, Hogben M, McDonald S . Development of risk reduction behavioral counseling for Ebola virus disease survivors enrolled in the Sierra Leone Ebola Virus Persistence Study, 2015-2016. PLoS Negl Trop Dis. 2017; 11(9):e0005827. PMC: 5593175. DOI: 10.1371/journal.pntd.0005827. View

16.

Diallo B, Sissoko D, Loman N, Bah H, Bah H, Worrell M . Resurgence of Ebola Virus Disease in Guinea Linked to a Survivor With Virus Persistence in Seminal Fluid for More Than 500 Days. Clin Infect Dis. 2016; 63(10):1353-1356. PMC: 5091350. DOI: 10.1093/cid/ciw601. View

17.

Deen G, McDonald S, Marrinan J, Sesay F, Ervin E, Thorson A . Implementation of a study to examine the persistence of Ebola virus in the body fluids of Ebola virus disease survivors in Sierra Leone: Methodology and lessons learned. PLoS Negl Trop Dis. 2017; 11(9):e0005723. PMC: 5593174. DOI: 10.1371/journal.pntd.0005723. View

18.

Henao-Restrepo A, Camacho A, Longini I, Watson C, Edmunds W, Egger M . Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!). Lancet. 2016; 389(10068):505-518. PMC: 5364328. DOI: 10.1016/S0140-6736(16)32621-6. View

19.

Sissoko D, Laouenan C, Folkesson E, MLebing A, Beavogui A, Baize S . Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea. PLoS Med. 2016; 13(3):e1001967. PMC: 4773183. DOI: 10.1371/journal.pmed.1001967. View

20.

Sneller M, Reilly C, Badio M, Bishop R, Eghrari A, Moses S . A Longitudinal Study of Ebola Sequelae in Liberia. N Engl J Med. 2019; 380(10):924-934. PMC: 6478393. DOI: 10.1056/NEJMoa1805435. View